We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Lumbar Interbody System Facilitates Bone Ingrowth

By HospiMedica International staff writers
Posted on 07 Oct 2021
A novel platform maximizes bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines implant delivery.

The Kleiner Device Labs (Incline Village, NV, USA) KG2 Surge flow-thru interbody device is 3-D printed titanium implant with a diamond lattice porous structure, and is intended for transforaminal lumbar interbody fusion (TLIF) and posterior lumbar interbody fusion (PLIF) procedures of the spine in skeletally mature patients with degenerative disc disease (DDD), and up to Grade One spondylolisthesis of the lumbar spine at one level or two contiguous levels, from L2 to S1. More...


Both autogenous and/or allogenic bone grafts, comprised of cancellous and/or corticocancellous bone graft can be used to facilitate fusion, with the implant's unique I-beam architecture and ramp design allowing unrestricted flow to bilaterally fill and integrate the implant into the prepared disc space. The KG2 Surge flow-thru interbody system comes with the interbody device pre-assembled with the cannula in a single-use sterile tray. To fill the disc space with bone graft, the implant is first inserted, the space distracted, and then packed with bone graft using the cannulated inserter.

“Getting adequate graft fill volume and distribution of graft within the intervertebral disc space is one of the most vexing challenges in spinal fusion procedures, which led us to develop the unique flow-thru technology in our KG series products,” said Jeff Kleiner, MD, founder and CEO of Kleiner Device Labs. “The KG2 Surge system works in both MIS and open approaches, and the reusable instrument package allows for immediate revision at every step, should the surgeon desire implant repositioning or removal.”

Interbody devices are designed to replace the intervertebral disc of the spine, enhancing stability in the region while the spine fuses. Over time, the packed bone graft material is gradually replaced by natural bone forming a solid piece. Fusion procedures typically use a posterior fixation device to the associated level, since the surgeons will implant interbody devices from an anterior approach and flip the patient over to implant a posterior pedicle screw device. This combination increases fusion success.

Related Links:
Kleiner Device Labs


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
IV Therapy Cart
Avalo I.V Therapy Cart
New
Portable Ventilator
Oxivent Oxi4Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.